Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis
2010 · JNCI Journal of the National Cancer Institute · 348 citations
https://doi.org/10.1093/jnci/djq101
H
Hal K. Berman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
226
Papers
5.3K
Citations
35
h-index
55
i10-index
Hal K. Berman is an academic researcher from University Health Network. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Cancer Cells and Metastasis & CAR-T cell therapy research. The author has an h-index of 35, co-authored 193 publications.
ORCID: 0000-0001-7524-7911Papers by this author
worksMolecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial
2016 · Genome Medicine · 275 citations
https://doi.org/10.1186/s13073-016-0364-2
Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
2021 · Nature Communications · 125 citations
https://doi.org/10.1038/s41467-021-25432-7
Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids
2022 · Nature Communications · 119 citations
https://doi.org/10.1038/s41467-022-28788-6
The origins of breast cancer associated with mammographic density: a testable biological hypothesis
2018 · Breast Cancer Research · 44 citations
https://doi.org/10.1186/s13058-018-0941-y
Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer
2017 · Breast Cancer Research and Treatment · 29 citations
https://doi.org/10.1007/s10549-017-4580-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat